scholarly article | Q13442814 |
P50 | author | Mark T. Young | Q40046312 |
Elena Adinolfi | Q42316269 | ||
Amanda B. MacKenzie | Q81487041 | ||
P2093 | author name string | Annmarie Surprenant | |
P2860 | cites work | Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus | Q24301114 |
Proteomic and functional evidence for a P2X7 receptor signalling complex | Q24535912 | ||
Integrin signaling | Q28142010 | ||
Molecular physiology of P2X receptors | Q28203477 | ||
Mitochondrial Regulation of Apoptosis | Q28204466 | ||
P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release | Q28205505 | ||
Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing | Q28210013 | ||
The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy | Q28280478 | ||
Extracellular ATP causes ROCK I-dependent bleb formation in P2X7-transfected HEK293 cells | Q28565083 | ||
Deletion of the P2X7 nucleotide receptor reveals its regulatory roles in bone formation and resorption | Q28594371 | ||
Apoptotic and necrotic blebs in epithelial cells display similar neck diameters but different kinase dependency | Q29032278 | ||
Mitochondria and apoptosis | Q29547905 | ||
Cell death: the significance of apoptosis | Q29617620 | ||
Carbohydrate analysis of glycoprotein hormones | Q30857710 | ||
Differential effects of bcl-2 on cell death triggered under ATP-depleting conditions. | Q31711489 | ||
Cytolytic P2X purinoceptors. | Q33592245 | ||
Functional and molecular diversity of purinergic ion channel receptors | Q33691550 | ||
Extranuclear apoptosis. The role of the cytoplasm in the execution phase | Q33718455 | ||
Mitochondria and cell death. Mechanistic aspects and methodological issues | Q33734610 | ||
Caspase activation without death | Q33782504 | ||
Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? | Q33787932 | ||
Focal adhesions - the cytoskeletal connection | Q33840319 | ||
Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. | Q33941102 | ||
Mitochondria as the central control point of apoptosis | Q33994978 | ||
Apoptosis: The Complex Scenario for a Silent Cell Death | Q34263672 | ||
Purinergic signaling and vascular cell proliferation and death | Q34555187 | ||
T-cell integrins: more than just sticking points | Q35576652 | ||
Caspase-independent cell death? | Q35743103 | ||
Programmed cell deaths. Apoptosis and alternative deathstyles | Q35750745 | ||
Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor | Q36276387 | ||
Two phases of signalling between mitochondria during apoptosis leading to early depolarisation and delayed cytochrome c release | Q40663595 | ||
Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor | Q40873751 | ||
P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death | Q40958387 | ||
The protonophore CCCP induces mitochondrial permeability transition without cytochrome c release in human osteosarcoma cells | Q43713494 | ||
Poly(ADP-ribose) polymerase activation and changes in Bax protein expression associated with extracellular ATP-mediated apoptosis in human embryonic kidney 293-P2X7 cells | Q44329273 | ||
NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor | Q44620463 | ||
The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. | Q44838329 | ||
Do inducers of apoptosis trigger caspase-independent cell death? | Q45267818 | ||
Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. | Q52536118 | ||
Apoptosis: a guide for the perplexed. | Q53456253 | ||
Apoptosis: caspases orchestrate the ROCK `n' bleb | Q57910004 | ||
P433 | issue | 40 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 9 | |
P304 | page(s) | 33968-33976 | |
P577 | publication date | 2005-06-30 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors | |
P478 | volume | 280 |
Q39834758 | A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. |
Q41760807 | Activated microglia cause reversible apoptosis of pheochromocytoma cells, inducing their cell death by phagocytosis |
Q43122227 | Activation of the P2X7 ion channel by soluble and covalently bound ligands |
Q34232228 | Activation of the Transcription Factor FosB/Activating Protein-1 (AP-1) Is a Prominent Downstream Signal of the Extracellular Nucleotide Receptor P2RX7 in Monocytic and Osteoblastic Cells* |
Q40813474 | C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation |
Q58785789 | Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer |
Q60929868 | Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells |
Q36695567 | Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock |
Q40133685 | Caveolin-1 influences P2X7 receptor expression and localization in mouse lung alveolar epithelial cells |
Q37203208 | Cell signaling via the P2X(7) nucleotide receptor: linkage to ROS production, gene transcription, and receptor trafficking |
Q42145843 | Characterisation of the R276A gain-of-function mutation in the ectodomain of murine P2X7 |
Q24622958 | Conserved ectodomain cysteines are essential for rat P2X7 receptor trafficking |
Q52645864 | Coordinate effects of P2X7 and extracellular acidification in microglial cells. |
Q34097900 | Corneal epithelium expresses a variant of P2X(7) receptor in health and disease |
Q50295208 | Cytokines Stimulate the Release of Microvesicles from Myeloid Cells Independently from the P2X7 Receptor/Acid Sphingomyelinase Pathway |
Q39708017 | Diadenosine homodinucleotide products of ADP-ribosyl cyclases behave as modulators of the purinergic receptor P2X7. |
Q39885707 | Expression of the P2X7 receptor increases the Ca2+ content of the endoplasmic reticulum, activates NFATc1, and protects from apoptosis |
Q30493112 | Externally triggered egress is the major fate of Toxoplasma gondii during acute infection |
Q61764006 | Extracellular ATP and P2 purinergic signalling in the tumour microenvironment |
Q35796263 | Extracellular ATP induces the rapid release of HIV-1 from virus containing compartments of human macrophages |
Q39971174 | Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. |
Q90289880 | From sunscreens to medicines: Can a dissipation hypothesis explain the beneficial aspects of many plant compounds? |
Q90524319 | Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization |
Q24295003 | Go it alone no more--P2X7 joins the society of heteromeric ATP-gated receptor channels |
Q41594118 | Identification of Thr283 as a key determinant of P2X7 receptor function |
Q47777431 | In situ imaging reveals properties of purinergic signalling in trigeminal sensory ganglia in vitro |
Q37123853 | Induction of caspase- and reactive oxygen species-independent phosphatidylserine externalization in primary human neutrophils: role in macrophage recognition and engulfment |
Q37139376 | Inhibition of P2X(7) receptors by divalent cations: old action and new insight |
Q63977060 | Invited Lectures : Overviews Purinergic signalling: past, present and future |
Q41969599 | Involvement of P2X7 receptor in neuronal degeneration triggered by traumatic injury. |
Q37232928 | Lymphocytes from P2X7-deficient mice exhibit enhanced P2X7 responses. |
Q38746852 | Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process |
Q42789183 | Many ways to dilate the P2X7 receptor pore |
Q24617046 | Molecular and functional properties of P2X receptors--recent progress and persisting challenges |
Q89457019 | Monocytes mediate homing of circulating microvesicles to the pulmonary vasculature during low-grade systemic inflammation |
Q60042076 | Novel macrophage polarization model: from gene expression to identification of new anti-inflammatory molecules |
Q37135491 | P2 purinergic receptor modulation of cytokine production |
Q39600738 | P2 receptor-mediated signaling in mast cell biology |
Q42087948 | P2X(7): a growth-promoting receptor-implications for cancer |
Q48601198 | P2X2 and P2X5 subunits define a new heteromeric receptor with P2X7-like properties. |
Q92799403 | P2X7 Interactions and Signaling - Making Head or Tail of It |
Q36200053 | P2X7 Receptor Function in Bone-Related Cancer |
Q28512950 | P2X7 nucleotide receptors mediate blebbing in osteoblasts through a pathway involving lysophosphatidic acid |
Q35621886 | P2X7 on Mouse T Cells: One Channel, Many Functions |
Q36417661 | P2X7 receptor activation regulates rapid unconventional export of transglutaminase-2. |
Q64903655 | P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis. |
Q24655197 | P2X7 receptors regulate multiple types of membrane trafficking responses and non-classical secretion pathways |
Q50096315 | POM-1 inhibits P2 receptors and exhibits anti-inflammatory effects in macrophages |
Q57369780 | PS externalization: from corpse clearance to drug delivery |
Q24306745 | Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor |
Q60927782 | Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme |
Q39354673 | Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release? |
Q24634398 | Polymorphisms in the P2X7 receptor gene are associated with low lumbar spine bone mineral density and accelerated bone loss in post-menopausal women |
Q91451598 | Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages |
Q37992053 | Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration |
Q90319935 | Purinergic signaling and tumor microenvironment in cervical Cancer |
Q46667650 | Purinergic signaling during macrophage differentiation results in M2 alternative activated macrophages |
Q42107837 | Quantitative Limits on Small Molecule Transport via the Electropermeome - Measuring and Modeling Single Nanosecond Perturbations. |
Q38902193 | Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors. |
Q92714923 | Self-Regulation of Memory CD8 T Cell Metabolism through Extracellular ATP Signaling |
Q35237387 | Serial Measurements of Apoptotic Cell Numbers Provide Better Acceptance Criterion for PBMC Quality than a Single Measurement Prior to the T Cell Assay |
Q34501183 | The P2X(7) loss-of-function Glu496Ala polymorphism affects ex vivo cytokine release and protects against the cytotoxic effects of high ATP-levels |
Q41786720 | The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. |
Q36882305 | The nucleotide receptor P2RX7 mediates ATP-induced CREB activation in human and murine monocytic cells |
Q34763427 | The role of nucleotides and purinergic signaling in apoptotic cell clearance - implications for chronic inflammatory diseases |
Q42876676 | The role of the purinergic P2X7 receptor in inflammation |
Q53702209 | Variations in Cellular Responses of Mouse T Cells to Adenosine-5'-Triphosphate Stimulation Do Not Depend on P2X7 Receptor Expression Levels but on Their Activation and Differentiation Stage. |
Search more.